📣 VC round data is live. Check it out!
- Public Comps
- PACS Group
PACS Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for PACS Group and similar public comparables like Sunway Healthcare, RadNet, Bumrungrad Hospital, Ramsay Health and more.
PACS Group Overview
About PACS Group
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Founded
2023
HQ

Employees
45.7K
Website
Sectors
Financials (LTM)
EV
$9B
Valuation Multiples
Start free trialPACS Group Financials
PACS Group reported last 12-month revenue of $5B and EBITDA of $527M.
In the same LTM period, PACS Group generated $1B in gross profit, $527M in EBITDA, and $243M in net income.
Revenue (LTM)
PACS Group P&L
In the most recent fiscal year, PACS Group reported revenue of $5B and EBITDA of $505M.
PACS Group is profitable as of last fiscal year, with gross margin of 15%, EBITDA margin of 10%, and net margin of 4%.
Financial data powered by Morningstar, Inc.
PACS Group Stock Performance
PACS Group has current market cap of $5B, and enterprise value of $9B.
Market Cap Evolution
PACS Group's stock price is $33.59.
PACS Group share price increased by 0.1% in the last 30 days, and by 238.6% in the last year.
PACS Group has an EPS (earnings per share) of $1.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $5B | 0.0% | 0.1% | -7.7% | 238.6% | $1.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPACS Group Valuation Multiples
PACS Group trades at 1.6x EV/Revenue multiple, and 16.2x EV/EBITDA.
EV / Revenue (LTM)
PACS Group Financial Valuation Multiples
As of May 11, 2026, PACS Group has market cap of $5B and EV of $9B.
PACS Group has a P/E ratio of 21.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PACS Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


PACS Group Margins & Growth Rates
PACS Group grew revenue by 8% and EBITDA by 12% in the last fiscal year.
In the most recent fiscal year, PACS Group reported gross margin of 15%, EBITDA margin of 10%, and net margin of 4%.
PACS Group Margins
PACS Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
PACS Group Operational KPIs
PACS Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
PACS Group's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
PACS Group's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
PACS Group Competitors
PACS Group competitors include Sunway Healthcare, RadNet, Bumrungrad Hospital, Ramsay Health, PureHealth, Aster DM Healthcare, Narayana Health, Kpj Healthcare, Mouwasat and Meinian Onehealth.
Most PACS Group public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 12.2x | 9.6x | 46.7x | 40.7x | |||
| 2.8x | 2.6x | 18.0x | 17.8x | |||
| 4.9x | 5.0x | 12.4x | 12.5x | |||
| 1.1x | 1.1x | 10.1x | 8.9x | |||
| 1.4x | 1.3x | 7.6x | 7.7x | |||
| 9.6x | 8.2x | 46.9x | 42.0x | |||
| 6.1x | 4.7x | 26.6x | 22.5x | |||
| 4.2x | 4.1x | 16.7x | 17.1x | |||
This data is available for Pro users. Sign up to see all PACS Group competitors and their valuation data. Start Free Trial | ||||||
PACS Group Funding History
Before going public, PACS Group raised $589M in total equity funding, across 1 round.
PACS Group Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PACS Group
| When was PACS Group founded? | PACS Group was founded in 2023. |
| Where is PACS Group headquartered? | PACS Group is headquartered in United States. |
| How many employees does PACS Group have? | As of today, PACS Group has over 45K employees. |
| Who is the CEO of PACS Group? | PACS Group's CEO is Jason Murray. |
| Is PACS Group publicly listed? | Yes, PACS Group is a public company listed on NYSE. |
| What is the stock symbol of PACS Group? | PACS Group trades under PACS ticker. |
| When did PACS Group go public? | PACS Group went public in 2024. |
| Who are competitors of PACS Group? | PACS Group main competitors include Sunway Healthcare, RadNet, Bumrungrad Hospital, Ramsay Health, PureHealth, Aster DM Healthcare, Narayana Health, Kpj Healthcare, Mouwasat, Meinian Onehealth. |
| What is the current market cap of PACS Group? | PACS Group's current market cap is $5B. |
| What is the current revenue of PACS Group? | PACS Group's last 12 months revenue is $5B. |
| What is the current revenue growth of PACS Group? | PACS Group revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of PACS Group? | Current revenue multiple of PACS Group is 1.6x. |
| Is PACS Group profitable? | Yes, PACS Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of PACS Group? | PACS Group's last 12 months EBITDA is $527M. |
| What is PACS Group's EBITDA margin? | PACS Group's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of PACS Group? | Current EBITDA multiple of PACS Group is 16.2x. |
| What is the current FCF of PACS Group? | PACS Group's last 12 months FCF is $303M. |
| What is PACS Group's FCF margin? | PACS Group's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of PACS Group? | Current FCF multiple of PACS Group is 28.2x. |
| How many companies PACS Group has acquired to date? | PACS Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies PACS Group has invested to date? | PACS Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to PACS Group
Lists including PACS Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.